Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2007 1
2008 2
2009 1
2010 7
2011 14
2012 17
2013 21
2014 23
2015 31
2016 32
2017 41
2018 50
2019 63
2020 98
2021 117
2022 146
2023 114
2024 47

Text availability

Article attribute

Article type

Publication date

Search Results

717 results

Results by year

Filters applied: . Clear all
Page 1
Targeting HECTD3-IKKα axis inhibits inflammation-related metastasis.
Li F, Liang H, You H, Xiao J, Xia H, Chen X, Huang M, Cheng Z, Yang C, Liu W, Zhang H, Zeng L, Wu Y, Ge F, Li Z, Zhou W, Wen Y, Zhou Z, Liu R, Jiang D, Xie N, Liang B, Liu Z, Kong Y, Chen C. Li F, et al. Among authors: liu z. Signal Transduct Target Ther. 2022 Aug 3;7(1):264. doi: 10.1038/s41392-022-01057-0. Signal Transduct Target Ther. 2022. PMID: 35918322 Free PMC article.
Anti-drug Antibody Validation Testing and Reporting Harmonization.
Myler H, Pedras-Vasconcelos J, Phillips K, Hottenstein CS, Chamberlain P, Devanaryan V, Gleason C, Goodman J, Manning MS, Purushothama S, Richards S, Shen H, Zoghbi J, Amaravadi L, Barger T, Bowen S, Bowsher RR, Clements-Egan A, Geng D, Goletz TJ, Gunn GR, Hallett W, Hodsdon ME, Janelsins BM, Jawa V, Kamondi S, Kirshner S, Kramer D, Liang M, Lindley K, Liu S, Liu Z, McNally J, Mikulskis A, Nelson R, Ahbari MR, Qu Q, Ruppel J, Snoeck V, Song A, Yan H, Ware M. Myler H, et al. Among authors: liu z. AAPS J. 2021 Dec 1;24(1):4. doi: 10.1208/s12248-021-00649-y. AAPS J. 2021. PMID: 34853961 Free PMC article.
Neoadjuvant pyrotinib, trastuzumab, and docetaxel for HER2-positive breast cancer (PHEDRA): a double-blind, randomized phase 3 trial.
Wu J, Jiang Z, Liu Z, Yang B, Yang H, Tang J, Wang K, Liu Y, Wang H, Fu P, Zhang S, Liu Q, Wang S, Huang J, Wang C, Wang S, Wang Y, Zhen L, Zhu X, Wu F, Lin X, Zou J. Wu J, et al. Among authors: liu z. BMC Med. 2022 Dec 27;20(1):498. doi: 10.1186/s12916-022-02708-3. BMC Med. 2022. PMID: 36575513 Free PMC article. Clinical Trial.
Early detection of visual impairment in young children using a smartphone-based deep learning system.
Chen W, Li R, Yu Q, Xu A, Feng Y, Wang R, Zhao L, Lin Z, Yang Y, Lin D, Wu X, Chen J, Liu Z, Wu Y, Dang K, Qiu K, Wang Z, Zhou Z, Liu D, Wu Q, Li M, Xiang Y, Li X, Lin Z, Zeng D, Huang Y, Mo S, Huang X, Sun S, Hu J, Zhao J, Wei M, Hu S, Chen L, Dai B, Yang H, Huang D, Lin X, Liang L, Ding X, Yang Y, Wu P, Zheng F, Stanojcic N, Li JO, Cheung CY, Long E, Chen C, Zhu Y, Yu-Wai-Man P, Wang R, Zheng WS, Ding X, Lin H. Chen W, et al. Among authors: liu z. Nat Med. 2023 Feb;29(2):493-503. doi: 10.1038/s41591-022-02180-9. Epub 2023 Jan 26. Nat Med. 2023. PMID: 36702948
Pyrotinib plus capecitabine for patients with human epidermal growth factor receptor 2-positive breast cancer and brain metastases (PERMEATE): a multicentre, single-arm, two-cohort, phase 2 trial.
Yan M, Ouyang Q, Sun T, Niu L, Yang J, Li L, Song Y, Hao C, Chen Z, Orlandi A, Ishii N, Takabe K, Franceschini G, Ricci F, Verschraegen C, Liu Z, Zhang M, Lv H, Liu L, Yang X, Xiao H, Gao Z, Li X, Dong F, Chen X, Qiao J, Zhang G. Yan M, et al. Among authors: liu z. Lancet Oncol. 2022 Mar;23(3):353-361. doi: 10.1016/S1470-2045(21)00716-6. Epub 2022 Jan 31. Lancet Oncol. 2022. PMID: 35085506 Clinical Trial.
Neoadjuvant docetaxel plus carboplatin vs epirubicin plus cyclophosphamide followed by docetaxel in triple-negative, early-stage breast cancer (NeoCART): Results from a multicenter, randomized controlled, open-label phase II trial.
Zhang L, Wu ZY, Li J, Lin Y, Liu Z, Cao Y, Zhang G, Gao HF, Yang M, Yang CQ, Zhu T, Cheng MY, Ji F, Li J, Wang K. Zhang L, et al. Among authors: liu z. Int J Cancer. 2022 Feb 15;150(4):654-662. doi: 10.1002/ijc.33830. Epub 2021 Oct 7. Int J Cancer. 2022. PMID: 34591977 Free article. Clinical Trial.
Functioning and mechanisms of PTMs in renal diseases.
Liu Z, Yang J, Du M, Xin W. Liu Z, et al. Front Pharmacol. 2023 Nov 21;14:1238706. doi: 10.3389/fphar.2023.1238706. eCollection 2023. Front Pharmacol. 2023. PMID: 38074159 Free PMC article. Review.
717 results